Supplemental Table 1 from KT-253, a Novel MDM2 Degrader and p53 Stabilizer, Has Superior Potency and Efficacy than MDM2 Small-Molecule Inhibitors
Authors:
- Yogesh K. ChutakeYCYogesh K. Chutake
- Michele F. MayoMMMichele F. Mayo
- Nancy DumontNDNancy Dumont
- Jessica FiliatraultJFJessica Filiatrault
- Susanne B. BreitkopfSBSusanne B. Breitkopf
- Patricia ChoPCPatricia Cho
- Dapeng ChenDCDapeng Chen
- Vaishali S. DixitVDVaishali S. Dixit
- William R. ProctorWPWilliam R. Proctor
- Eric W. KuhnEKEric W. Kuhn
- Sarah Bollinger MartinezSMSarah Bollinger Martinez
- Alice A. McDonaldAMAlice A. McDonald
Open Access
- 17 June 2026
- other
- Published by American Association for Cancer Research (AACR)